Often regulatory and procurement issues arise that uniquely or disproportionately target U.S. subsidiaries of companies headquartered abroad. OFII works to ensure that policymakers do not subject U.S. subsidiaries to unnecessary or burdensome regulations that may discourage investment and job creation in the U.S.
While U.S. subsidiaries actively partner with the U.S. federal government on issues of critical importance - including advanced research in clean energy technology and supplying emergency vaccines - their “foreign” heritage is frequently leveraged against them to overturn existing contracts or deny access to new government contracts. OFII opposes these discriminatory restrictions and works to ensure an open, competitive U.S. procurement process.
Issue areas include: